Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …

Allergic rhinitis (AR) and asthma represent global health problems for all age groups.
Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on …

The selection of pharmacotherapy for patients with allergic rhinitis aims to control the disease
and depends on many factors. Grading of Recommendations Assessment, Development …

Several unmet needs have been identified in allergic rhinitis: identification of the time of
onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, …

Reported COVID‐19 deaths in Germany are relatively low as compared to many European
countries. Among the several explanations proposed, an early and large testing of the …

A novel strain of human coronaviruses, named by the International Committee on
Taxonomy of Viruses (ICTV) 1 as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …

The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several
factors, including age, prominent symptoms, symptom severity, control of AR, patient …

Background Allergic rhinitis (AR) is increasingly acknowledged as having a substantial
socioeconomic impact associated with impaired work productivity, although available information …

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis
and/or asthma. Many guidelines or national practice guidelines have been produced but …

Background The coronavirus disease 2019 (COVID‐19) has evolved into a pandemic
infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS‐CoV‐…